Form 4: Teradyne Director Sells Shares Under 10b5-1 Plan
Statement of Changes in Beneficial Ownership
Director Mercedes Johnson of Teradyne, Inc. has reported the sale of 167 shares of common stock under a pre-arranged trading plan.
Summary
- Director Mercedes Johnson reported a sale of 167 shares of Teradyne, Inc. common stock on June 2, 2026.
- The transaction was executed under a Rule 10b5-1 trading plan adopted on March 4, 2026.
- The sale price was $369.74 per share.
- Following this transaction, the reporting person directly beneficially owns 6,864 shares.
- An additional 1,876 shares are held indirectly by The Mercedes Johnson Trust, where the reporting person serves as trustee and sole beneficiary.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine stock sale by a director under a pre-established plan, which is standard practice and does not inherently signal positive or negative sentiment about the company's future.
Negatives
- Director Mercedes Johnson sold 167 shares of common stock.
Future Outlook
The filing does not contain forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that the use of Rule 10b5-1 plans is a common and accepted practice for corporate insiders to sell shares without violating insider trading regulations, providing a structured way to diversify holdings or meet financial obligations.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Rule 10b5-1 Plan Adoption | Reporting Person adopted a written trading plan intended to comply with Rule 10b5-1 for the purchase or sale of equity securities. | 03/04/2026 | Facilitates orderly stock transactions by insiders while adhering to regulatory requirements. |
Stakeholder Impact
- Shareholders: The sale by a director may be perceived by some shareholders as a signal, though the use of a 10b5-1 plan mitigates concerns about insider trading based on material non-public information.
Key Dates
| Date | Description |
|---|---|
| 03/04/2026 | Date the Rule 10b5-1 sales plan was adopted by the Reporting Person. |
| 06/02/2026 | Date of the reported transaction (sale of common stock). |
| 06/03/2026 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
Teradyne, Form 4, SEC Filing, Insider Trading, Rule 10b5-1, Stock Sale, Director Transaction, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.